Spectrum Conference
Jan 15, 2026
Jan 17, 2026
Miami, Florida
Building on over 70 years of innovation, Cambridge Interventional is advancing the future of thermal ablation with RFA systems crafted for precision, designed for ease of use, and dedicated to better patient outcomes.
Backed by over 70 years of expertise, the Cambridge CRF System empowers clinicians to perform radiofrequency ablation with confidence across a wide range of applications in the thyroid, liver, kidney, bone, uterus, lung, and beyond. Its advanced algorithms, high power output, and superior usability work together to enable large, controlled ablations, streamlining complex procedures and delivering results beyond the limits of other RFA systems.
The CRF radiofrequency ablation system combines cutting-edge technology with a range of powerful features to deliver distinct benefits for both clinicians and their patients.
“The new Cambridge Interventional system offers an extremely handy device with excellent ultrasound visibility…[the system] is very useful for both experienced and novice users.”
– Dr. Giovanni Mauri, MD
Head of the Research Laboratory on Minimally Invasive Image-Guided Treatments of the Thyroid, Unit of Diagnostic and Interventional Radiology
IRCCS Ospedale Galeazzi Sant’Ambrogio, Milan, Italy
How Radiofrequency Ablation is Transforming Benign Thyroid Nodule Treatment
Download the white paper to explore how RFA is reshaping thyroid care—offering a minimally invasive alternative to surgery and delivering effective, tissue-preserving results for patients with benign thyroid nodules.
See how the RFA System from Cambridge Interventional transforms soft tissue ablation with leading precision and clinical efficiency.
Savannah, Georgia
Lexington, Kentucky
Wailea, HI
Philadelphia, Pennsylvania
